CELYAD ONCOLOGY Soars 30% As Trading Day Closes!
(VIANEWS) – CELYAD ONCOLOGY (BEL 20: CYAD.BR) shares surged 30.85% to EUR0.98 at 15:30 EST Friday, building on two consecutive sessions of gains and extending an earlier uptrend by 0.06% to EUR3,668.26; this trend suggests positive momentum so far. About CELYAD ONCOLOGY Celyad Oncology is a clinical-stage biopharmaceutical company specializing in CAR-T cell therapy for…